4/8
05:10 pm
ymab
Form SC 13G Y-mAbs Therapeutics, Filed by: Paradigm Biocapital Advisors LP
Low
Report
Form SC 13G Y-mAbs Therapeutics, Filed by: Paradigm Biocapital Advisors LP
3/14
05:02 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Mar 12 Filed by: TAGLIAFERRI MARY
Low
Report
Form 4 Y-mAbs Therapeutics, For: Mar 12 Filed by: TAGLIAFERRI MARY
3/14
09:18 am
ymab
Form 8-K Y-mAbs Therapeutics, For: Mar 08
Medium
Report
Form 8-K Y-mAbs Therapeutics, For: Mar 08
3/8
06:17 am
ymab
Form 3 Y-mAbs Therapeutics, For: Feb 29 Filed by: TAGLIAFERRI MARY
Medium
Report
Form 3 Y-mAbs Therapeutics, For: Feb 29 Filed by: TAGLIAFERRI MARY
3/7
05:02 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Rajah Vignesh
Low
Report
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Rajah Vignesh
3/7
05:01 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Gad Thomas
Low
Report
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Gad Thomas
3/7
05:00 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Smith Susan Laura
Low
Report
Form 4 Y-mAbs Therapeutics, For: Mar 05 Filed by: Smith Susan Laura
3/6
04:49 pm
ymab
Form 144 Y-mAbs Therapeutics, Filed by: Smith Susan Laura
Low
Report
Form 144 Y-mAbs Therapeutics, Filed by: Smith Susan Laura
3/6
04:40 pm
ymab
Form 144 Y-mAbs Therapeutics, Filed by: Rajah Vignesh
Low
Report
Form 144 Y-mAbs Therapeutics, Filed by: Rajah Vignesh
3/5
07:06 pm
ymab
Form 144 Y-mAbs Therapeutics, Filed by: Gad Thomas
Medium
Report
Form 144 Y-mAbs Therapeutics, Filed by: Gad Thomas
3/4
06:06 am
ymab
Form 8-K Y-mAbs Therapeutics, For: Feb 29
Medium
Report
Form 8-K Y-mAbs Therapeutics, For: Feb 29
2/29
05:07 pm
ymab
Form S-8 Y-mAbs Therapeutics,
High
Report
Form S-8 Y-mAbs Therapeutics,
2/29
04:20 pm
ymab
Form 10-K Y-mAbs Therapeutics, For: Dec 31
High
Report
Form 10-K Y-mAbs Therapeutics, For: Dec 31
2/29
04:04 pm
ymab
Form 8-K Y-mAbs Therapeutics, For: Feb 29
High
Report
Form 8-K Y-mAbs Therapeutics, For: Feb 29
2/14
04:30 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Feb 12 Filed by: Rossi Michael J
Medium
Report
Form 4 Y-mAbs Therapeutics, For: Feb 12 Filed by: Rossi Michael J
2/14
04:11 pm
ymab
Form SC 13G/A Y-mAbs Therapeutics, Filed by: WG Biotech ApS
Low
Report
Form SC 13G/A Y-mAbs Therapeutics, Filed by: WG Biotech ApS
2/13
05:24 pm
ymab
Form SC 13G/A Y-mAbs Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Y-mAbs Therapeutics, Filed by: VANGUARD GROUP INC
2/13
04:09 pm
ymab
Form SC 13G/A Y-mAbs Therapeutics, Filed by: HBM Healthcare Investments (Cayman) Ltd.
Low
Report
Form SC 13G/A Y-mAbs Therapeutics, Filed by: HBM Healthcare Investments (Cayman) Ltd.
2/6
04:00 pm
ymab
Form SC 13G/A Y-mAbs Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
Medium
Report
Form SC 13G/A Y-mAbs Therapeutics, Filed by: ACORN BIOVENTURES, L.P.
1/26
05:27 pm
ymab
Form SC 13G/A Y-mAbs Therapeutics, Filed by: BlackRock Inc.
Medium
Report
Form SC 13G/A Y-mAbs Therapeutics, Filed by: BlackRock Inc.
1/22
06:02 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Rajah Vignesh
Low
Report
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Rajah Vignesh
1/22
06:00 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Smith Susan Laura
Low
Report
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Smith Susan Laura
1/22
05:58 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Lisby Steen
Low
Report
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Lisby Steen
1/22
05:57 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Wilms Joris
Low
Report
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Wilms Joris
1/22
05:54 pm
ymab
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Lund-Hansen Torben
Low
Report
Form 4 Y-mAbs Therapeutics, For: Jan 18 Filed by: Lund-Hansen Torben